MyAverix Finance
HK · Healthcare
Fusen Pharmaceutical Company Ltd (1652)
Drug Manufacturers - Specialty & Generic
Fusen Pharmaceutical Company Ltd (1652) is listed on HK in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-21, reported market cap is $813.23M, P/E ratio is 18.00, net margin is -4.3%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 1652
Fusen Pharmaceutical Company Ltd (1652) — FAQ
What is Fusen Pharmaceutical Company Ltd's market cap?
Fusen Pharmaceutical Company Ltd (1652) has a reported market cap of $813.23M (data as of 2026-05-21).
What is 1652's P/E ratio?
The price-to-earnings (P/E) ratio for Fusen Pharmaceutical Company Ltd (1652) is 18.00 (data as of 2026-05-21).
Does Fusen Pharmaceutical Company Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Fusen Pharmaceutical Company Ltd (1652). Check the MyAverix Finance app for the latest dividend data.
What sector is Fusen Pharmaceutical Company Ltd in?
Fusen Pharmaceutical Company Ltd (1652) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 1652 listed on?
1652 is listed on HK.
What is Fusen Pharmaceutical Company Ltd's net margin?
Fusen Pharmaceutical Company Ltd (1652) reports a net margin of -4.3% (data as of 2026-05-21).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.